|
|
|
|
WHO, Wyeth Launch Trial In Africa To Test New River Blindness Drug
The WHO on Wednesday announced plans for a clinical trial to test a new drug that 'could halve the treatment period for river blindness [or onchocerciasis], a disease that threatens 100 million people mostly in Africa,' reports (7/1)....
|
|
|
WHO, Wyeth Launch Trial In Africa To Test New River Blindness Drug
Tropical Diseases News Main Category: Tropical Diseases Also Included In: Pharma Industry / Biotech Industry email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health Professional...
|
|
|
New Drug That Could Dramatically Speed Up The Elimination Of River Blindness Across Africa Begins Clinical Tri
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa.The drug, moxidectin, is being investigated...
|
|
|
Canadian Bio Med Attacks World's Leading Cause of Blindness
NEW YORK, MONTREAL and SAN DIEGO, CA, June 30 /PRNewswire-FirstCall/ -- Canadian Bio Med Systems Inc., a subsidiary of ICBS Ltd., (OTCPK: ICBT), and Ocular Therapeutics Inc.of San Diego California, announced the development of a new AMD...
|
|
|
WHO, Wyeth To Start Clinical Trial On New River Blindness Drug
The World Health Organization said Wednesday it was launching a clinical trial for a drug that could halve the treatment period for river blindness, a disease that threatens 100 million people mostly in Africa.The phase three trial of the...
|
|
|
WHO, Wyeth To Start Clinical Trial On New River Blindness Drug
GENEVA (AFP)--The World Health Organization said Wednesday it was launching a clinical trial for a drug that could halve the treatment period for river blindness, a disease that threatens 100 million people mostly in Africa.The phase...
|
|
|
AGTC And National Neurovision Research Institute Collaborate, Funding Research In Two Genetic Retinal Diseases
Applied Genetic Technologies Corporation (AGTC), a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that AGTC has entered into an agreement with the National Neurovision...
|
|
|
Jean Bennett and Albert Maguire: Gene Therapy to Reverse Near-Blindness
For Jean Bennett and Albert Maguire, sharing a human brain in a neuroanatomy class stirred up a personal chemistry that produced a marriage and three kids.It led to a 25-year professional partnership as well, a collaboration that has...
|
|
|
Prevent Blindness America Approves PediaVision Assessment Solution
PediaVision, a company dedicated to solving the critical problem of undiagnosed vision problems affecting thousands of children, today announced that Prevent Blindness America, www.preventblindness.org, has approved the PediaVision...
|
|
|
AGTC and National Neurovision Research Institute Collaborate, Funding Research in two Genetic Retinal Diseases
- Applied Genetic Technologies Corporation (AGTC), a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that AGTC has entered into an agreement with the National Neurovision...
|
|
|
AGTC and National Neurovision Research Institute Collaborate, Funding Research in two Genetic Retinal Diseases
Applied Genetic Technologies Corporation (AGTC), a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that AGTC has entered into an agreement with the National Neurovision...
|
|
|
AGTC and National Neurovision Research Institute Collaborate, Funding Research in two Genetic Retinal Diseases
GAINESVILLE, Fla.(Business Wire) -- Applied Genetic Technologies Corporation (AGTC), a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that AGTC has entered into an...
|
|
|
AGTC and National Neurovision Research Institute Collaborate, Funding Research in two Genetic Retinal Diseases
GAINESVILLE, Fla.--(BUSINESS WIRE)-- Applied Genetic Technologies Corporation (AGTC), a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that AGTC has entered into an...
|
|
|
Medical News: Will Individuals With Alzheimer's Disease Benefit From Cataract Surgery?
Alzheimer's / Dementia News Main Category: Alzheimer's / Dementia Also Included In: Eye Health / Blindness email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health...
|
|
|
Medical News: Volunteers Needed For QUT Eye Study, Australia
News Archive [link] Web Wikipedia Medical Dictionary [link] login | register Eye Health / Blindness News Main Category: Eye Health / Blindness Also Included In: Clinical Trials / Drug Trials email to a friend printer friendly...
|
|
|
Medical News: Center For Vision Restoration Of UPMC And Pitt Receives Multi-Million Dollar Gift To Be Matched
Eye Health / Blindness News Main Category: Eye Health / Blindness email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health Professional: Article Opinions: The Center...
|
|
|
BBC Examines River Blindness Program In Sub-Saharan Africa
News Archive [link] Web Wikipedia Medical Dictionary [link] login | register Tropical Diseases News Main Category: Tropical Diseases Also Included In: Infectious Diseases / Bacteria / Viruses email to a friend printer friendly view / write...
|
|
|
New Results In Fight Against Blindness Revealed
The CARMA Study Group, representing leading researchers at Queens University, Belfast and the Waterford Institute of Technology will unveil the results of a 5 year project into age-related macular degeneration (AMD) on Friday, 19th June at...
|
|
|
New Results In Fight Against Blindness Revealed
The CARMA Study Group, representing leading researchers at Queens University, Belfast and the Waterford Institute of Technology will unveil the results of a 5 year project into age-related macular degeneration (AMD) on Friday, 19th June at...
|
|
|
PBO warns of the potential danger of fireworks
Columbus, OHPrevent Blindness Ohio (PBO) urges the public to refrain from purchasing or using backyard fireworks for Fourth of July celebrations.Approximately 6,300 Americans were treated in emergency rooms across the country in...
|
|
|
JustAnswer And Glaucoma Research Foundation Help Individuals See The Light In Preventing Blindness
JustAnswer, the website where people go when they need answers from Doctors, Lawyers, Mechanics or other Experts, today announced it is partnering with the Glaucoma Research Foundation (GRF), as part of Vision Research Month.The...
|
|
|
A Stem-Cell Therapy for Blindness
An experimental therapy using human embryonic stem cells to treat degenerative eye diseases has proved safe and effective in animal studies, and may begin early human trials in the next few months if it receives approval from the Food and...
|
|
|
FDA Taking Steps To Improve Contact Lens Safety
Eye Health / Blindness News Main Category: Eye Health / Blindness Also Included In: Regulatory Affairs / Drug Approvals email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient /...
|
|
|
PBO, PBA award grants in celebration of Vision Research Awareness Month
Columbus, OHPrevent Blindness Ohio (PBO), along with Prevent Blindness America (PBA), has named June as Vision Research Awareness month.Its mission is to advocate for vision research and assist in providing researchers with...
|
|
|
Inattentional Blindness: What Captures Your Attention?
_ Inattentional Blindness: What Captures Your Attention?.
|
